
Loading, please wait...

Loading, please wait...

AIIMS Delhi researchers have made a significant breakthrough in Gut-Bone Axis Research. They discovered that a molecule produced in the gut helps protect bones from inflammation-driven damage. This finding offers a promising new path to tackle osteoporosis. Consequently, doctors may soon look beyond traditional calcium supplements to maintain skeletal health. Bone strength often depends on a complex balance of cellular activity influenced by the microbiome.
Researchers specifically focused on deoxycholic acid (DCA). This secondary bile acid is a compound naturally produced by gut bacteria. Notably, the team found that DCA levels are significantly lower in patients suffering from osteoporosis and bone loss. Furthermore, the molecule demonstrates a dual effect on bone metabolism. It effectively suppresses bone-resorbing osteoclasts while boosting bone-forming osteoblasts. This balance is vital for preventing the fragility associated with aging.
The study, published in Biomedicine & Pharmacotherapy, highlights the importance of the Gut-Bone Axis Research. In animal models, DCA significantly reduced bone damage caused by inflammation. Moreover, the compound strengthened the gut lining and helped restore healthy bacterial populations. Therefore, maintaining a healthy gut microbiome might be as crucial as physical activity for bone density. The researchers observed that DCA regulates key pathways that control how bones form and break down over time.
Dr. Rupesh K. Srivastava, who led the study at AIIMS, suggests two future treatment strategies. Physicians could eventually supplement DCA directly or use probiotics to enhance the gut bacteria that produce it. However, clinical trials in humans are necessary before these findings can change standard practice. For now, the message remains clear. Caring for your gut is vital for long-term bone health. Additionally, this research could reshape how specialists treat various metabolic bone diseases.
Q1: What is the gut-bone axis?
The gut-bone axis is the physiological link between the gut microbiome and bone metabolism. Molecules like bile acids produced in the gut can influence the activity of bone-forming and bone-resorbing cells.
Q2: How does deoxycholic acid (DCA) improve bone strength?
DCA improves bone strength by reducing inflammatory signals that cause bone loss. Simultaneously, it increases the production of osteoblasts, which are the cells responsible for building new bone tissue.
Q3: Can patients start taking DCA supplements now?
No, the current findings are based on animal studies. Dr. Srivastava cautions that human clinical trials are required to ensure safety and efficacy before it can be recommended for patient use.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


AIIMS Delhi researchers find deoxycholic acid (DCA) from gut bacteria protects against osteoporosis by boosting bone formation and reducing inflammation....
4 months ago

A preclinical study in mice reveals how ambient temperature and lighting modulate sleep-associated metabolic and thermoregulatory rhythms. Cold conditions increase nocturnal fat oxidation and lower body temperature, while thermoneutrality blunts these shifts, offering key insights for cardiometabolic health.
Today

India has achieved a historic public health milestone by administering over 80 lakh HPV vaccine doses to adolescent girls. Integrated into the U-WIN network and administered across government healthcare facilities, this nationwide campaign offers vital protection against cervical cancer and associated HPV infections.
Today

A new investigation demonstrates that middle cerebral artery blood velocity reactivity during the cold pressor test exhibits robust between-visit reproducibility comparable to systemic blood pressure, confirming its utility as a reliable neurovascular biomarker.
Today

A retrospective cohort study demonstrates that patients with anorexia nervosa and bulimia nervosa face significantly higher risks of lower extremity soft tissue injuries, including ACL tears and ligament sprains, along with heightened rates of orthopedic revision surgery, highlighting the need for systemic screening.
Today

The Supreme Court rejected industry pleas for per-serve metrics, directing FSSAI to provide a firm timeline for mandatory front-of-pack food warning labels. Clinicians welcome this crucial regulatory intervention to curb rising rates of obesity, hypertension, and pediatric metabolic syndrome across India.
Today